0001342792 false --07-31 2022 Q2 0001342792 2021-08-01 2022-01-31 0001342792 2022-03-11 0001342792 2022-01-31 0001342792 2021-07-31 0001342792 us-gaap:SeriesAPreferredStockMember 2022-01-31 0001342792 us-gaap:SeriesAPreferredStockMember 2021-07-31 0001342792 us-gaap:SeriesBPreferredStockMember 2022-01-31 0001342792 us-gaap:SeriesBPreferredStockMember 2021-07-31 0001342792 2021-11-01 2022-01-31 0001342792 2020-11-01 2021-01-31 0001342792 2020-08-01 2021-01-31 0001342792 WWSG:SerieAPreferredStockMember 2020-07-31 0001342792 WWSG:SerieBPreferredStockMember 2020-07-31 0001342792 us-gaap:CommonStockMember 2020-07-31 0001342792 us-gaap:AdditionalPaidInCapitalMember 2020-07-31 0001342792 us-gaap:RetainedEarningsMember 2020-07-31 0001342792 2020-07-31 0001342792 WWSG:SerieAPreferredStockMember 2020-10-31 0001342792 WWSG:SerieBPreferredStockMember 2020-10-31 0001342792 us-gaap:CommonStockMember 2020-10-31 0001342792 us-gaap:AdditionalPaidInCapitalMember 2020-10-31 0001342792 us-gaap:RetainedEarningsMember 2020-10-31 0001342792 2020-10-31 0001342792 WWSG:SerieAPreferredStockMember 2021-07-31 0001342792 WWSG:SerieBPreferredStockMember 2021-07-31 0001342792 us-gaap:CommonStockMember 2021-07-31 0001342792 us-gaap:AdditionalPaidInCapitalMember 2021-07-31 0001342792 us-gaap:RetainedEarningsMember 2021-07-31 0001342792 WWSG:SerieAPreferredStockMember 2021-10-31 0001342792 WWSG:SerieBPreferredStockMember 2021-10-31 0001342792 us-gaap:CommonStockMember 2021-10-31 0001342792 us-gaap:AdditionalPaidInCapitalMember 2021-10-31 0001342792 us-gaap:RetainedEarningsMember 2021-10-31 0001342792 2021-10-31 0001342792 WWSG:SerieAPreferredStockMember 2020-08-01 2020-10-31 0001342792 WWSG:SerieBPreferredStockMember 2020-08-01 2020-10-31 0001342792 us-gaap:CommonStockMember 2020-08-01 2020-10-31 0001342792 us-gaap:AdditionalPaidInCapitalMember 2020-08-01 2020-10-31 0001342792 us-gaap:RetainedEarningsMember 2020-08-01 2020-10-31 0001342792 2020-08-01 2020-10-31 0001342792 WWSG:SerieAPreferredStockMember 2020-11-01 2021-01-31 0001342792 WWSG:SerieBPreferredStockMember 2020-11-01 2021-01-31 0001342792 us-gaap:CommonStockMember 2020-11-01 2021-01-31 0001342792 us-gaap:AdditionalPaidInCapitalMember 2020-11-01 2021-01-31 0001342792 us-gaap:RetainedEarningsMember 2020-11-01 2021-01-31 0001342792 WWSG:SerieAPreferredStockMember 2021-08-01 2021-10-31 0001342792 WWSG:SerieBPreferredStockMember 2021-08-01 2021-10-31 0001342792 us-gaap:CommonStockMember 2021-08-01 2021-10-31 0001342792 us-gaap:AdditionalPaidInCapitalMember 2021-08-01 2021-10-31 0001342792 us-gaap:RetainedEarningsMember 2021-08-01 2021-10-31 0001342792 2021-08-01 2021-10-31 0001342792 WWSG:SerieAPreferredStockMember 2021-11-01 2022-01-31 0001342792 WWSG:SerieBPreferredStockMember 2021-11-01 2022-01-31 0001342792 us-gaap:CommonStockMember 2021-11-01 2022-01-31 0001342792 us-gaap:AdditionalPaidInCapitalMember 2021-11-01 2022-01-31 0001342792 us-gaap:RetainedEarningsMember 2021-11-01 2022-01-31 0001342792 WWSG:SerieAPreferredStockMember 2021-01-31 0001342792 WWSG:SerieBPreferredStockMember 2021-01-31 0001342792 us-gaap:CommonStockMember 2021-01-31 0001342792 us-gaap:AdditionalPaidInCapitalMember 2021-01-31 0001342792 us-gaap:RetainedEarningsMember 2021-01-31 0001342792 2021-01-31 0001342792 WWSG:SerieAPreferredStockMember 2022-01-31 0001342792 WWSG:SerieBPreferredStockMember 2022-01-31 0001342792 us-gaap:CommonStockMember 2022-01-31 0001342792 us-gaap:AdditionalPaidInCapitalMember 2022-01-31 0001342792 us-gaap:RetainedEarningsMember 2022-01-31 0001342792 us-gaap:ConvertiblePreferredStockMember 2021-08-01 2022-01-31 0001342792 us-gaap:ConvertiblePreferredStockMember 2020-08-01 2021-01-31 0001342792 us-gaap:ConvertibleDebtMember 2021-08-01 2022-01-31 0001342792 us-gaap:ConvertibleDebtMember 2020-08-01 2021-01-31 0001342792 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ConvertibleDebtMember 2022-01-31 0001342792 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ConvertibleDebtMember 2022-01-31 0001342792 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ConvertibleDebtMember 2022-01-31 0001342792 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-01-31 0001342792 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-01-31 0001342792 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-01-31 0001342792 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ConvertibleDebtMember 2021-07-31 0001342792 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ConvertibleDebtMember 2021-07-31 0001342792 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ConvertibleDebtMember 2021-07-31 0001342792 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-07-31 0001342792 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-07-31 0001342792 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-07-31 0001342792 WWSG:CeoAndCfoMember 2021-11-01 2022-01-31 0001342792 WWSG:CeoAndCfoMember 2022-01-31 0001342792 WWSG:PayableToShareholderMember 2022-01-31 0001342792 WWSG:PayableToShareholderMember 2021-07-31 0001342792 WWSG:CeoAndCfoMember 2021-08-01 2022-01-31 0001342792 WWSG:ConvertibleNote1Member 2022-01-31 0001342792 WWSG:ConvertibleNote1Member 2021-07-31 0001342792 WWSG:ConvertibleNote1Member 2021-08-01 2022-01-31 0001342792 WWSG:ConvertibleNote2Member 2021-07-31 0001342792 WWSG:ConvertibleNote2Member 2022-01-31 0001342792 WWSG:ConvertibleNote2Member 2021-08-01 2022-01-31 0001342792 WWSG:ConvertibleNote3Member 2022-01-31 0001342792 WWSG:ConvertibleNote3Member 2021-07-31 0001342792 WWSG:ConvertibleNote3Member 2021-08-01 2022-01-31 0001342792 WWSG:ConvertibleNote4Member 2022-01-31 0001342792 WWSG:ConvertibleNote4Member 2021-07-31 0001342792 WWSG:ConvertibleNote4Member 2021-08-01 2022-01-31 0001342792 WWSG:ConvertibleNote4Member srt:MinimumMember 2021-08-01 2022-01-31 0001342792 WWSG:ConvertibleNote4Member srt:MaximumMember 2021-08-01 2022-01-31 0001342792 WWSG:ConvertibleNote5Member 2022-01-31 0001342792 WWSG:ConvertibleNote5Member 2021-07-31 0001342792 WWSG:ConvertibleNote5Member 2021-08-01 2022-01-31 0001342792 WWSG:ConvertibleNote5Member srt:MinimumMember 2021-08-01 2022-01-31 0001342792 WWSG:ConvertibleNote5Member srt:MaximumMember 2021-08-01 2022-01-31 0001342792 WWSG:SerieBPreferredStockMember 2022-01-31 0001342792 WWSG:FitwellMember 2021-09-01 2021-09-24 0001342792 us-gaap:SubsequentEventMember 2022-02-01 2022-02-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

	For the quarterly period ended January 31, 2022

or

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

	For the transition period from _____ to _____

Commission File Number: 000-52362

WORLDWIDE STRATEGIES INC.

(Exact Name of Registrant as Specified in its Charter)

Nevada

41-0946897

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

1961 NW 150 AVENUE, SUITE 205

PEMBROKE PINES, FL

33028

(Address of principal executive offices)

(Zip code)

1 844 500 9974

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(g) of the Act:

Title of each class	Trading Symbol (s)	Name of each exchange on which registered

Common Stock, $0.001 par value	WWSG	OTC

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or, an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company”, in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐		Accelerated filer ☐
Non-accelerated filer ☒		Smaller reporting company ☒
		Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Securities registered pursuant to Section 12(b) of the Act: None

As of March 11, 2022, there were 19,830,679 shares of the registrant’s common stock, $0.001 par value, outstanding.

TABLE OF CONTENTS

	Part I. Financial Information	Page No.

Item 1.	Financial Statements of Worldwide Strategies, Inc.

	Balance Sheets - January 31, 2022 (Unaudited) and July 31, 2021	3

	Statements of Operations - Three and Six Months Ended January 31, 2022 and 2021 (Unaudited)	4

	Statement of Changes in Stockholders’ Deficit - Six Months Ended January 31, 2022 and 2021 (Unaudited)	5

	Statements of Cash Flows - Three and Six Months Ended January 31, 2022 and 2021 (Unaudited)	6

	Notes to Financial Statements - Three Months Ended January 31, 2022 and 2021 (Unaudited)	7



Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	11

Item 3.	Quantitative and Qualitative Disclosures about Market Risk	12

Item 4.	Controls and Procedures	12

	Part II. Other Information

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	13

Item 5.	Other Information	13

Item 6.	Exhibits	13

SIGNATURES		14

PART 1. FINANCIAL INFORMATION

Item 1. Financial Statements

Worldwide Strategies, Inc.

Balance Sheets

January 31, 2022 and July 31, 2021


	January 31, 2022 (Unaudited)			July 31, 2021 (Audited)
Assets
Current Assets:
Cash	$	–		$	–
Total assets	$	–		$	–
Liabilities and Stockholders' Deficit
Current Liabilities:
Accounts payable	$	42,967		$	42,967
Accrued liabilities		400,028			375,504
Convertible notes payable, in default		452,406			452,406
Convertible notes payable, related party - in default		40,000			40,000
Total current liabilities		935,401			910,877

Long term notes payable - related party		31,952			14,577

Total Liabilities		967,353			925,454

Stockholders' deficit:
Preferred Stock; $.001 par value; 25,000,000 shares authorized
Series A, 5,000,000 shares issued and outstanding		5,000			5,000
Series B, 270,000 shares issued and outstanding		270			270
Common stock, $.001 par value, 975,000,000 shares authorized 19,830,679 shares issued and outstanding, respectively		19,831			19,831
Additional paid-in capital		14,497,273			14,497,273
Accumulated deficit		(15,489,727	)		(15,447,828	)
Total Stockholders' Deficit		(967,353	)		(925,454	)
Total Liabilities and Stockholders' Deficit	$	–		$	–

See accompanying notes to condensed financial statements.

Worldwide Strategies, Inc.

Statement of Operations

For the three and six months ended January 31, 2022 and 2021

(Unaudited)


	Three Months Ended January 31,						Six Months Ended January 31,
	2022			2021			2022			2021
Operating expenses:
Other general and administrative expenses	$	3,330		$	300		$	17,215		$	600
Total operating expenses		3,330			300			17,215			600
Loss from operations		(3,330	)		(300	)		(17,215	)		(600	)
Other expense:
Interest expense		(12,463	)		(11,900	)		(24,684	)		(23,800	)
Total other expenses		(12,463	)		(11,900	)		(24,684	)		(23,800	)

Loss before income taxes		(15,793	)		(12,200	)		(41,899	)		(24,400	)
Income tax provision		–			–			–			–
Net loss	$	(15,793	)	$	(12,200	)	$	(41,899	)	$	(24,400	)

Basic and diluted loss per share	$	0.00		$	0.00		$	0.00		$	0.00

Basic and diluted weighted average common shares outstanding		19,830,679			19,830,679			19,830,679			19,830,679

See accompanying notes to condensed financial statements.

Worldwide Strategies, Inc.

Statement of Changes in Stockholders’ Deficit

For the three and six months ended January, 2021 and 2020

(Unaudited)


	Preferred Stock								Common Stock
	Series A				Series B
	Shares		Par Value		Shares		Par Value		Shares		Par Value		Additional Paid-In Capital		Accumulated Deficit			Total


Balance July 31, 2020		1,491,743	$	1,492		270,000	$	270		19,830,679	$	19,831	$	13,185,185	$	(14,070,055	)	$	(863,277	)
Net Loss		–		–		–		–		–		–		–		(12,200	)		(12,200	)
Balance October 31, 2020		1,491,743	$	1,492		270,000	$	270		19,830,679	$	19,831	$	13,185,185	$	(14,082,255	)	$	(875,477	)

Net Loss		–		–		–		–		–		–		–		(12,200	)		(12,200	)
Balance January 31, 2021		1,491,743	$	1,492		270,000	$	270		19,830,679	$	19,831	$	13,185,185	$	(14,094,455	)	$	(887,677	)

	Preferred Stock								Common Stock
	Series A				Series B
	Shares		Par Value		Shares		Par Value		Shares		Par Value		Additional Paid-In Capital		Accumulated Deficit			Total
Balance at July 31, 2021		5,000,000	$	5,000		270,000	$	270		19,830,679	$	19,831	$	14,497,273	$	(15,447,828	)	$	(925,454	)
Net Loss		–		–		–		–		–		–		–		(26,106	)		(26,106	)
Balance October 31, 2021		5,000,000	$	5,000		270,000	$	270		19,830,679	$	19,831	$	14,497,273	$	(15,473,934	)	$	(951,560	)

Net Loss		–		–		–		–		–		–		–		(15,793	)		(15,793	)
Balance January 31, 2022		1,491,743	$	1,492		270,000	$	270		19,830,679	$	19,831	$	13,185,185	$	(15,489,727	)	$	(967,353	)

See accompanying notes to condensed financial statements.

Worldwide Strategies, Inc.

Statement of Cash Flows

For the six months ended January 31, 2022 and 2021

(Unaudited)


	Six Months Ended January 31,
	2022			2021
Cash flows from operating activities:
Net loss	$	(41,899	)	$	(24,400	)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock Based Compensation		–			–
Accrued liabilities		24,524			23,800
Net cash used in operating activities		(17,375	)		(600	)

Cash flows from financing activities:
Related party loans		17,375			600
Net cash provided by financing activities		17,375			600

Net increase in cash		–			–

Cash, beginning of period		–			–
Cash, end of period	$	–		$	–

Supplemental disclosure of cash flow information:

Cash paid for taxes	$	–		$	–

Cash paid for interest	$	–		$	–

See accompanying notes to condensed financial statements.

Worldwide Strategies, Inc.

NOTES TO FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED JANUARY 31, 2022 and 2021

(Unaudited)

Note 1 – Organization and Basis of Presentation,

Organization and Basis of Presentation

Worldwide Strategies Incorporated (“WWSG” or the “Company”) was incorporated under the laws of the State of Nevada on April 6, 1998 and ceased operations in 2015. The Company fully impaired all assets since the shutdown of its operations in 2015. On May 7, 2019, the eight judicial District Court of Nevada appointed Small Cap Compliance, LLC (“Custodian”) as custodian for Worldwide Strategies Incorporated., proper notice having been given to the officers and directors of Worldwide Strategies Incorporated with no opposition. On July 10, 2019, the Company filed a Certificate of Reinstatement with the state of Nevada.

The accompanying financial statements are prepared on the basis of accounting principles generally accepted in the United States of America (“GAAP”) and have been prepared assuming the continuation of the Company as a going concern. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and is dependent on debt and equity financing to fund its operations. Management of the Company is making efforts to raise additional funding until a registration statement relating to an equity funding facility is in effect. While management of the Company believes that it will be successful in its capital formation and planned operating activities, there can be no assurance that the Company will be able to raise additional equity capital or be successful in the development and commercialization of the products it develops or initiates collaboration agreements thereon. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.

Note 2 – Summary of significant accounting policies

Cash and Cash Equivalents

The Company doesn’t maintain any bank accounts and does not have any cash in hand. For day-to-day business activities, the Company depends upon the directors’ personal accounts. For purposes of reporting within the statements of cash flows, the Company considers all cash on hand, cash accounts not subject to withdrawal restrictions or penalties, and all highly liquid debt instruments purchased with a maturity of three months or less to be cash and cash equivalents.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Loss per Common Share

Net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding for the period. As a result, diluted loss per common share is the same as basic loss per common share for the three and six months ended January 31, 2022 and 2021. Excluded from the weighted average common shares outstanding amount is convertible preferred stock equivalent to 301,250,000 and convertible debt equivalent to 45,393,500 common shares as the effect of these on the computation of net loss per share would have been anti-dilutive.

Income Taxes

The Company accounts for income taxes pursuant to FASB ASC Topic 740, Income Taxes. Under FASB ASC Topic 740, deferred tax assets and liabilities are determined based on temporary differences between the bases of certain assets and liabilities for income tax and financial reporting purposes. The deferred tax assets and liabilities are classified according to the financial statement classification of the assets and liabilities generating the differences.

The Company maintains a valuation allowance with respect to deferred tax assets. The Company establishes a valuation allowance based upon the potential likelihood of realizing the deferred tax asset and taking into consideration the Company’s financial position and results of operations for the current period. Future realization of the deferred tax benefit depends on the existence of sufficient taxable income within the carry-forward period under the Federal tax laws.

Changes in circumstances, such as the Company generating taxable income, could cause a change in judgment about the reliability of the related deferred tax asset. Any change in the valuation allowance will be included in income in the year of the change in estimate.

Fair Value of Financial Instruments

On August 1, 2012, the Company adopted ASC 820, Fair Value Measurements and Disclosures. ASC 820 defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The three levels are defined as follows:

	·	Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
	·	Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
	·	Level 3 inputs to valuation methodology are unobservable and significant to the fair measurement.

The following tables represent our assets and liabilities by level measured at fair value on a recurring basis at January 31, 2022 and July 31, 2021:

Fair Value Measurements at January 31, 2022

Level 1

Level 2

Level 3

Description

Convertible Debt

–

492,406

–

Total Liabilities

–

492,406

–

Totals

–

492,406

–

Fair Value Measurements at July 31, 2021

Level 1

Level 2

Level 3

Description

Convertible Debt

–

492,406

–

Total Liabilities

–

492,406

–

Totals

–

492,406

–

Reclassifications

Certain reclassifications have been made to the prior year presentation to conform to the current year presentation.

Recent Accounting Pronouncements

The Company reviewed all the recently issued, but not yet effective, accounting pronouncements and we do not believe any of these pronouncements will have a material impact on the Company.

Note 3- Going Concern

For the three months ended January 31, 2022 and 2021 we incurred net losses of approximately $16,000 and $12,000 respectively. As of January 31, 2022, we had no cash on hand and current liabilities of approximately $1 million. As of July 31, 2021, we had no cash on hand and current liabilities of $0.9 million. These losses combined with our current liabilities cast significant doubt on the company’s ability to operate under the going concern. The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management intends to finance operating costs over the next twelve months with loans from directors and/or private placement of common stock. The failure to achieve the necessary levels of profitability or obtaining additional funding would be detrimental to the Company.

Note 4 – Related party transactions

The Company’s CFO has provided office space at no cost to the Company. Our CEO and CFO incurred expenses on behalf of the Company amounting to approximately $3,000 during the three months ending January 31, 2022. As of January 31, 2022 total amounts due to our CEO and CFO are approximately $32,000. These amounts are due on June 30, 2023 and bear interest at eight percent per annum.

As of January 31, 2022 and July 31, 2021, the Company had a convertible promissory note in the principal outstanding balance of $40,000, payable to a shareholder. Such note bears interest at nine percent per annum with a maturity date of July 31, 2015. The principal and accrued interest is convertible, at the option of the holder, into common shares at $.01 per share.

Note 5 – Convertible Notes Payable

The Company has convertible promissory notes that in the aggregate result in a principal outstanding balance of $160,750 as of January 31, 2022 and July 31, 2021, respectively. Interest on these notes range from nine to ten percent per annum and such notes had maturity dates of July 31, 2015. The principal and accrued interest is convertible, at the option of the holder, into common shares at $.01 per share.

The Company has convertible promissory notes that in the aggregate result in a principal outstanding balance of $157,945 as of January 31, 2022 and July 31, 2021, respectively. Interest on these notes range from eight to ten percent per annum and such notes had maturity dates of July 31, 2015. The principal and accrued interest is convertible, at the option of the holder, into common shares at $.04 per share.

The Company has convertible promissory notes that in the aggregate result in a principal outstanding balance of $50,000 as of January 31, 2022 and July 31, 2021, respectively. Interest on these notes are 8% per annum and such notes had maturity date of March 31, 2015. The principal and accrued interest is convertible, at the option of the holder, into non-restricted common stock in an amount equal to the total sum due, based on a mutually agreed discount (not to exceed 50%) to the then market price.

The Company has convertible promissory notes that in the aggregate result in a principal outstanding balance of $44,711 as of January 31, 2022 and July 31, 2021, respectively. Interest on these notes are 10% per annum and such notes had maturity dates ranging from July 31, 2015 to December 31, 2015. The principal and accrued interest is convertible, at the option of the holder, into common shares at $.07 per share.

The Company has convertible promissory notes that in the aggregate result in a principal outstanding balance of $39,000 as of January 31, 2022 and July 31, 2021, respectively. Interest on these notes are 10% per annum and such notes had maturity dates ranging from July 31, 2015 to December 31, 2015. The principal and accrued interest is convertible, at the option of the holder, into common shares at $.10 per share.

Accrued interest on such notes total $400,028 and $375,504 as of January 31, 2022 and July 31, 2021, respectively and are included within accrued liabilities on the accompanying balance sheet. Based on the maturity dates of the promissory notes, all promissory notes are in default.

Note 6 – Shareholders’ Equity

Preferred stock

The Company has two classes of preferred stock and is authorized to issue 25,000,000 shares of $.001 par value preferred stock. The Company's Board of Directors may divide and issue the preferred shares in series. Each Series, when issued, shall be designated to distinguish them from the shares of all other series. The relative rights and preferences of these series include preference of dividends, redemption terms and conditions, amount payable upon shares of voluntary or involuntary liquidation, terms and condition of conversion as well as voting powers.

Series A Preferred Stock

The Company is authorized to issue 5,000,000 shares of Convertible Series A Preferred Stock at a par value of $0.001. Each share of Series A Preferred Stock is convertible into 6.25 shares of common stock at the election of the holder. Each Series A share is entitled to 6.25 votes in any vote of the common stock holders. Series A shares are redeemable by the Company at $.50 per share with 15 days written notice. Series A shares are entitled to a 5% dividend preference and a participation interest in the remaining 95% dividend.

Series B Preferred Stock

The Company is authorized to issue 5,000,000 shares of Convertible Series B Preferred Stock at a par value of $0.001. Each share of Series B Preferred Stock is convertible into 1,000 shares of common stock at the election of the holder.

Common stock

As of January 31, 2022 and July 31, 2021, the Company was authorized to issue 975,000,000 shares of common stock respectively. Total shares outstanding at January 31, 2022 and July 31, 2021 were 19,830,679, respectively.

Note 7 - Income taxes

The Company accounts for income taxes under FASB ASC Topic 740, which requires use of the liability method. FASB ASC Topic 740 provides that deferred tax assets and liabilities are recorded based on the differences the tax basis of assets and liabilities and their carrying amounts for financial reporting purposes, referred to as temporary differences. As of January 31, 2022, the Company incurred a net operating loss and, accordingly, no provision for income taxes has been recorded. In addition, no benefit for income taxes has been recorded due to the uncertainty of the realization of any tax assets.

Based on the available objective evidence, including the Company's history of losses, management believes it is more likely than not, the net deferred tax assets will not be fully realizable. Accordingly, the Company provided for a full valuation allowance against its net deferred tax assets at January 31, 2022 and July 31, 2021. The Company had no uncertain tax positions as of January 31, 2022 and July 31, 2021.

Note 8 – Acquisition

On May 29, 2021, the Company entered into a binding letter of intent (the “LOI”) with Fitwell Limited a company organized under the laws of the United Kingdom (“Fitwell”) to acquire Fitwell and its fitness and nutrition app, that same letter of intent expired, pursuant to the terms therein on July 29, 2021. Subsequent thereto, on September 24, 2021, the Company entered into a contingent Stock Purchase Agreement (the “Agreement”) with Fitwell pursuant to which we have agreed to acquire one hundred percent of issued and outstanding shares of Fitwell for a purchase price of $1,000,000 payable in cash and our common stock. The Company and Fitwell mutually agreed to rescind the Stock Purchase Agreement.

On February 17, 2022, the Company entered into an asset purchase agreement with Fitwell, for the purchase of a copy of its native mobile fitness application, including all source codes and associated databases for use on the iOS and Android platforms. The purchase price for the assets is $500,000 and shares of the Company in the amount of $500,000. The purchase is contingent on the Company completing a capital raise, under Regulation A which generates no less than $2 million in proceeds to the Company.

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Cautionary Statement Regarding Forward-Looking Statements

This report contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward looking statements. Forward-looking statements are not statements of historical facts, but rather reflect our current expectations concerning future events and results. The words “may,” “will,” “anticipate,” “should,” “would,” “believe,” “contemplate,” “could,” “project,” “predict,” “expect,” “estimate,” “continue,” and “intend,” as well as other similar words and expressions of the future, are intended to identify forward-looking statements.

Factors that may cause actual results to differ from those results expressed or implied, include, but are not limited to, those listed under “Risk Factors” in our Registration Statement on Form 10-K for the year ended July 31, 2021 filed by the Company with the Securities and Exchange Commission (the “SEC”) on October 29, 2021.

These forward-looking statements generally relate to our plans, objectives and expectations for future events and include statements about our expectations, beliefs, plans, objectives, intentions, assumptions and other statements that are not historical facts. These statements are based upon our opinions and estimates as of the date they are made. Although we believe that the expectations reflected in these forward-looking statements are reasonable, such forward-looking statements are subject to known and unknown risks and uncertainties that may be beyond our control, which could cause actual results, performance and achievements to differ materially from results, performance and achievements projected, expected, expressed or implied by the forward-looking statements. While we cannot assess the future impact that any of these differences could have on our business, financial condition, results of operations and cash flows or the market price of shares of our common stock, the differences could be significant. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this report and you are urged to consider all such risks and uncertainties. In light of the uncertainty inherent in such forward-looking statements, you should not consider their inclusion to be a representation that such forward-looking matters will be achieved.

General Overview

Results of operations

Three months ended January 31, 2022 compared to the three months ended January 31, 2021

Net Loss

For the three months ended January 31, 2022 and 2021 we incurred net losses of approximately $16,000 and $12,000 respectively.

Revenue

For the three months ended January 31, 2022 and 2021, we generated no revenue.

Expenses

For the three months ended January 31, 2022 we incurred expenses of approximately $16,000 of which approximately $3,000 was primarily related to professional fees and $13,000 was primarily related to interest expense.

For the three months ended January 31, 2021 incurred expenses of approximately $12,000 which was primarily related to interest expense.

Six months ended January 31, 2022 compared to the six months ended January 31, 2021

Net Loss

For the six months ended January 31, 2022 and 2021 we incurred net losses of approximately $42,000 and $24,000 respectively.

Revenue

For the six months ended January 31, 2022 and 2021, we generated no revenue.

Expenses

For the six months ended January 31, 2022 we incurred expenses of approximately $42,000 of which approximately $17,000 was primarily related to professional fees and $25,000 was primarily related to interest expense.

For the six months ended January 31, 2021 incurred expenses of approximately $24,000 which was primarily related to interest expense.

Financial condition

Liquidity and Capital Resources

Currently, we rely on our management to provide us with the capital needed to run our business on a day-to-day basis.

For the three months ended January 31, 2022 and 2021 we incurred net losses of approximately $16,000 and $12,000 respectively. As of January 31, 2022 we had no cash on hand and current liabilities of $1 million. As of July 31, 2021, we had no cash on hand and current liabilities of $0.9 million.

We will seek additional funds through equity or debt financing, collaborative or other arrangements with corporate partners, licensees or others, and from other sources, which may have the effect of diluting the holdings of existing shareholders. The Company has no current arrangements with respect to, or sources of, such additional financing and we do not anticipate that existing shareholders will provide any portion of our future financing requirements.

No assurance can be given that additional financing will be available when needed or that such financing will be available on terms acceptable to the Company. If adequate funds are not available, we may be required to delay or terminate expenditures for certain of its programs that it would otherwise seek to develop and commercialize. This would have a material adverse effect on the Company.

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Not required.

Item 4.

Controls and Procedures

The Company’s principal executive officer and principal financial officer, with the assistance of other members of the Company’s management, have evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this quarterly report. Based upon such evaluation, the Company’s principal executive officer and principal financial officer have concluded that the Company’s disclosure controls and procedures are not effective as of the end of the period covered by this quarterly report.

The Company’s principal executive officer and principal financial officer have also concluded that there was no change in the Company’s internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the Exchange Act) that occurred during the quarter ended January 31, 2022 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II. OTHER INFORMATION

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds.

Purchases of Equity Securities

We did not, nor did any affiliated purchaser, make any repurchases of our securities during the six months ended January 31, 2022.

Item 5.

Other Information

None

Item 6.

Exhibits.

Exhibit No.		Description
2.1		Notice of Entry of Order Appointing, Eight Judicial District Court, Clark County, Nevada, Case No.: A-19-791451-P dated May 7, 2019 (Filed as an exhibit to Form 10-12G on June 21, 2021).
2.2		Notice of Entry of Order Discharging, Eight Judicial District Court, Clark County, Nevada, Case No.: A-19-791451-P dated October 16, 2019 (Filed as an exhibit to Form 10-12G on June 21, 2021).
3.1		Amended and Restated Articles of Incorporation (Filed as an exhibit to Form SB-2, File No. 333-129398, on November 2, 2005).
3.2		Amended Bylaws (Filed as an exhibit to Form SB-2, File No. 333-129398, on November 2, 2005).
3.3		Certificate of Change Pursuant to NRS 78.209 effective July 31, 2007 (Filed as an exhibit to the Form 8-K dated July 31, 2007, filed August 6, 2007).
3.4		Certificate of Designation Pursuant to NRS 78.1955 effective December 8, 2008 (Filed as an exhibit to Form 8-K dated December 8, 2008, filed December 10, 2008).
3.5		Amendment to Certificate of Designation Pursuant to NRS 78.1955 effective December 15, 2008 (Filed as an exhibit to the Form 8-K dated December 15, 2008, filed December 17, 2008).
3.6		Certificate of Reinstatement dated July 10, 2019 (Filed as an exhibit to Form 10-12G on June 21, 2021).
3.7		Certificate of Designation dated July 10, 2019 (Filed as an exhibit to Form 10-12G on June 21, 2021).
3.8		Certificate of Amendment by Custodian filed July 10, 2019 (Filed as an exhibit to Form 10-12G on June 21, 2021).
3.9		Certificate of Amendment Filed July 10, 2019 (Filed as an exhibit to Form 10-12G on June 21, 2021).
3.11		Certificate of Amendment to the Articles of Incorporation Filed May 26, 2021 (Filed as an exhibit to Form 10-12G on June 21, 2021).
10		Intellectual Property License Agreement Between Worldwide Strategies Incorporated and Dr. Sandra Kaufmann (Filed as an exhibit to Form 10-12G on June 21, 2021)
10.1		2005 Stock Plan (Filed as an exhibit to the initial filing of the registration statement on Form SB-2, File No. 333-129398, on November 2, 2005).
21.1	*	List of Subsidiaries
24.1		Power of Attorney
31.1	*	Certification of principal executive officer of the Company, pursuant to Securities Exchange Act Rule 13a-14(a)
31.2	*	Certification of principal financial officer of the Company, pursuant to Securities Exchange Act Rule 13a-14(a)
32.1	*	Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of The Sarbanes-Oxley Act of 2002, signed by the principal executive officer of the Company and the principal financial officer of the Company

101.INS	*	Inline XBRL Instance Document

101.SCH	*	Inline XBRL Taxonomy Extension Schema Document

101.CAL	*	Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF	*	lnline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB	*	Inline XBRL Extension Labels Linkbase Document

101.PRE	*	Inline XBRL Taxonomy Extension Presentation Linkbase Document

104		Cover Page Interactive Data File (formatted in iXBRL, and included in exhibit 101).

*Filed herewith

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	WORLDWIDE STRATEGIES, INC.

	By:	/s/ ADAM LAUFER
		Name: Adam Laufer Title: Chief Executive Officer (Principal Executive Officer)

Date: March 15, 2022

	WORLDWIDE STRATEGIES, INC.

	By:	/s/ PAVAN CHARAN
		Name: Pavan Charan Title: Chief Financial Officer and Principal Accounting Officer (Principal Financial Officer)

Date: March 15, 2022

WORLDWIDE STRATEGIES INC 10-Q